Summary: Bladder Cancer Study Intravesical Treatment

Ages Eligible for Study: 18 Years and above,
Genders Eligible for Study: Both

Inclusion Criteria
(what you must have in order to enter the trial):

Disease Characteristics

• You have Transitional Cell Carcinoma (TCC) of the bladder
• You have Carcinoma In Situ (CIS), with or without non-invasive papillary disease (Ta or T1)
• The cancer cells express the EpCAM molecule (which you will be tested for once you enter the study)
• You have received BCG therapy within the past 2 years for this bladder cancer but the cancer persisted or came back

Prior/Concurrent Therapy

• It has been at least 2 months since the last dose of anti-cancer therapy (eg, chemotherapy, biological therapy, or photodynamic therapy) or any investigational therapy.

Patient Characteristics

• No hydronephrosis
• No significant liver or kidney disease

Other

• Patients must not become pregnant while participating in this trial

Exclusion Criteria
(reasons you will not be allowed to enter into the trial):

• You have muscle-invasive bladder cancer
• Your bladder cancer has spread outside of the bladder
• You have a severe urinary tract infection
• You can not tolerate intravesical administration

For more information, contact:

AdvanceMed Research
2 Princess Road, Suite J
Lawrenceville, NJ 08648
Telephone: 609-895-0735

Fill out our Volunteer Form to receive information on how to participate in one of our clinical trials.